Skip to main content
Clinical Trials/NCT03397056
NCT03397056
Completed
Not Applicable

How Participants Perceive Biomedical Research in Pulmonology

University Hospital, Montpellier2 sites in 1 country500 target enrollmentMarch 7, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Biomedical Research
Sponsor
University Hospital, Montpellier
Enrollment
500
Locations
2
Primary Endpoint
The PROTOACCEPT2 questionnaire.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Detailed Description

Over time, clinical research has become a challenge both in terms of public health and in terms of scientific progress. Additionally, it has also become a financial challenge for institutions, especially in France where a significant part of their government funding is provided according to their ability to conduct quality clinical research. Pulmonology is a sector where clinical research is well established with strong incentives from several pharmaceutical companies and numerous academic research projects. Nevertheless, it is important to put the patient back at the centre of biomedical research. A better knowledge of patient expectations, questions and misunderstandings would considerably improve treatment observance, clinical trial data quality, doctor-patient trust/relationship, and ultimately, the patient's health. The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project. The secondary objectives are to determine: * how biomedical research is experienced / felt; * if the information delivered to the patient (orally - information note) is clearly perceived. Comparisons with PROTOACCEPT1 (osf.io/nsjjr) will also be performed.

Registry
clinicaltrials.gov
Start Date
March 7, 2018
End Date
December 31, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient presents with at least one of the following: (1) asthma, (2) chronic obstructive pulmonary disease, (3) bronchiectasis, (4) idiopathic pulmonary fibrosis, (5) pulmonary arterial hypertension, (6) sleep apnoea syndrome
  • The patient is participating in a biomedical research protocol.

Exclusion Criteria

  • Patient under 18 years of age
  • Patient judged incapable of filling out the questionnaire for linguistic or other reasons.
  • The patient has already participated in the present study.

Outcomes

Primary Outcomes

The PROTOACCEPT2 questionnaire.

Time Frame: day 0 (transversal study)

Study Sites (2)

Loading locations...

Similar Trials